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Problem Identification
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Chronic venous disease (CVD) is commonly assessed using the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification
Chronic Venous Insufficiency (CVI) is characterized as patients with more advanced clinical signs of CVD (C3-C6) 
CEAP Classification1 of Chronic Venous Disease
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Progression of venous insufficiency
C4 = Stasis Dermatitis
 CVI skin changes in western countries range from <1%-40% in women and <1%-17% in men2
 Progression to stasis dermatitis (C4) is most common in people >50 years old in the USA with an overall disease 
prevalence of 6-7%3 in patients >50 years old
 In Vermont, 18.1% of people are >65 years old and specifically in Bennington County 22.1% of people are >65 
years, demonstrating a large population at risk of developing or actively managing stasis dermatitis without 
taking into account people ages 50-654
 One study found an association between symptoms of venous insufficiency and increased BMI in people from 
Burlington, Vermont and Leiden, Netherlands5
 In Vermont, 56% of the population >45 years old are considered obese6 and in Bennington County 24.1%7 of the 
total population are considered obese, thus further increasing the risk of these populations developing or 
managing stasis dermatitis
 According to the AAFP8, the prevalence of venous stasis ulcers (C5-C6) is 1% in the USA, and of people in the USA 
affected by venous stasis ulcers, the recurrence rate is 72% 9
 Complications of venous ulcers include osteomyelitis, cellulitis and malignant changes, thus developing venous 
stasis ulcers significantly increases a patient’s mortality rate10,11
 Key Problem:
• The complications of stasis dermatitis including venous ulcers, osteomyelitis, and cellulitis all 
significantly increase morbidity and mortality of disease 
• Progression beyond stasis dermatitis and avoidance of the aforementioned complications are 
preventable with patient education and adherence to basic therapies including compression 
stockings and lifestyle modification
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 Therefore, the questions needing to be addressed are: (1) What is our patients’ understanding of stasis dermatitis? (2) Are they aware of the 
complications associated with disease progression? (3) Do they know when to come see a provider for worsening symptoms of venous insufficiency beyond 
stasis dermatitis? (4) What are the barriers to treating stasis dermatitis and preventing disease progression?
Public Health Cost
 Estimated financial burden of $1.9-2.5 billion dollars per year in the USA for venous stasis ulcers9,12
 Average total medical cost of $9685 per patient for 3 months of venous stasis ulcer treatment9
 In 2016, Vermont had 135,668 total Medicare beneficiaries (22% of total VT population)13
 This is higher than the national average (18%) of Medicare beneficiaries as a percent of the total population 
 The financial burden of progression of CVI beyond stasis dermatitis is an enormous Medicare expense since people >50 years old are 
predominantly affected
 In 2016, there were 9,116 Bennington County beneficiaries of Medicare13 which was 25% of the Bennington County population
 This has increased from 8,591 Bennington County beneficiaries of Medicare in 2014,14 which was 24% of the Bennington County population
 As of 2014, in Bennington County the standardized risk-adjusted per capita Medicare cost was $8,473.1514 which is higher than the majority 
of counties in Vermont
 Medicare does not cover compression stockings/garments in their insurance plan, limiting access to an affordable preventative therapy 
3
Thus, there is a large proportion of Medicare dollars being 
spent on CVI beyond stasis dermatitis which could be saved 
with relatively inexpensive interventions including 
compression stockings, exercise, and weight loss. Through 
preventative measures, expanded insurance coverage, and 
appropriate management of stasis dermatitis prior to venous 
ulcer formation we can decrease the burden of cost in 
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Do your patients understand the potential consequences of stasis dermatitis?
“I don’t [think so] because patients 
who have had this for a long time 
look at this [stasis dermatitis] as their 
norm.”
“I try to explain it to them but the 
truth is, is that most patients don’t 
understand it.”
“For the most part the patients are 
unaware across the board unless they 
have had nursing interventions 
before.”
“No I don’t think they do generally 
speaking. People don’t seem to 
appreciate that covering up a 
problem, such as with trousers, 
doesn’t get rid of that problem.”
Do you think your patients understand when to come see their provider for worsening symptoms of venous insufficiency beyond stasis 
dermatitis?
“Not always, they don’t realize the 
severity and complications that can 
occur. They say ‘it will heal on its 
own’ if they have a venous ulcer 
developing. They typically initially try 
to manage the symptoms 
themselves, but they will come in 
with increased drainage, pain, and 
redness around the lesion.”
“If they have had it for a while with 
recurrent symptoms then yes they 
do, but not initially. If they have had 
multiple episodes of treatment with 
improvement, then they will return
with worsening symptoms.”
“No, overall patients have no clue.
They know their legs get big and their 
shoes don’t fit but they won’t start 
going to see a provider unless it is 
painful, they have an ulcer, or a 
provider picks it up in the office.”
“Most people don’t see discoloration 
or itching as something that will take 
them to the doctor’s office. Also, 
many people don’t have a primary 
care provider at all because they 
either want to avoid the doctor’s 
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What are some of the barriers your patients face in treating stasis dermatitis?
“The frequency of needing to be seen 
by a provider or resistance to letting 
someone into their home such as a 
visiting nurse; the cost of treatment 
can be very expensive; and it is hard 
for patients in this age group to get 
compression stockings on. The zipper 
compression stockings are expensive 
and insurance won’t give it to them at 
first.”
“Being proactive, exercising, eating
the right food, low salt [diet], losing 
weight, and using compression socks.”
“Following through on their part; 
moisturizing and not scratching.”
“[Barriers are] based on cost, access, 
and self-management ability.” 
“Access to compression stockings and 
the secondary problem is being able 
to put them on. This is very 
problematic for morbidly obese and 
elderly patients.”
“The biggest barrier is compression 
stockings, they are really difficult for 
patients to manage.”
“There are many creams and 
moisturizers out there and people try 
all of that stuff. They are told they 
need to moisturize their legs, but the 
content of the moisturizers can be 
very allergenic so finding products 
that people are not sensitive to is a 
huge problem.”
What are the barriers you as a provider face in counseling/managing these patients/their stasis dermatitis?  
“Compliance, time (office visit length), 
supplies to treat in the office. 
Education-wise, there isn’t much 
material that is written on this that I 
can give to patients since I want to 
make sure it is in language they can 
understand.”
“Getting the patient back into the 
office multiple times to reinforce the 
importance of treatment. Follow up is 
much more important than the 
primary visit.”
“Access to [insurance] coverage for 
garments/stockings for long term 
management and patient buy in,
which takes more than a 5-10 minute
office session.”
“Trying to convince people that they 
need to change their lifestyle and 
they need to be part of the solution 
to the problem that they have.
We are all individuals and all have 
habits that we grow into.”
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Methodology
Goals of the Project
 Assess the community’s understanding of stasis dermatitis and their 
awareness of its complications 
 Use this information to help healthcare providers tailor their 
preventative health counseling accordingly 
 Provide education for patients on stasis dermatitis, its complications, 
and therapies/behavioral changes to prevent disease progression
Methodology
 13 patients at Battenkill Valley Health Center between 1/1/2017-
12/13/2017 were identified by the electronic health records as 
having a diagnosis of stasis dermatitis or chronic venous insufficiency 
 Stasis Dermatitis Questionnaire administered to a total of 7 of the 
selected patients; 6 via telephone and 1 in person
 1 patient chose to abstain from the questionnaire
 5 patients were unable to be reached
 No identifying information was collected
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Intervention
 Developed an educational handout on stasis dermatitis for healthcare providers to distribute 
to qualified patients
 Devise recommendations for future preventative counseling based on analysis of survey data
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Results & Responses
Stasis Dermatitis Questionnaire Results
 Our patient’s understanding of stasis dermatitis and its complications
 Relatively poor 
 71% of patients surveyed have had symptoms of stasis dermatitis for more than 3 years, yet only 43% of patients correctly 
identified all of the symptoms that would warrant a visit to a healthcare provider (pain, redness, pus-like drainage, or open-
wound/ulcer).
 Patients with history of complications from CVI
 57% of patients experienced at least one complication as a result of their CVI including a skin infection, skin ulcer, or bone 
infection indicating poorly controlled disease within this sample population
 Patients who had been spoken to about stasis dermatitis by a healthcare provider 
 86% of patients stated that they had not been counseled on the complications of untreated symptoms of stasis dermatitis and 
57% of patients stated they had not been counseled on ways to prevent stasis dermatitis and its progression by a healthcare 
provider demonstrating an opportunity for education 
 Patients who have attempted to manage their stasis dermatitis with leg elevation and/or gradient 
compression stockings
 86% of patients have tried to elevate their legs for symptom relief and 71% of patients have tried gradient compression 
stockings at least once to prevent symptoms
 Patients who have attempted to manage their stasis dermatitis with exercise, weight loss and/or 
medication
 57% of patients exercise, 29% intentionally lost weight since the onset of their symptoms, and 29% of patients are taking 
medications/treating their symptoms in some alternative way
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Community Perspective Responses
 Unanimously providers interviewed agree that the majority of patients do not understand the potential 
consequences of stasis dermatitis
 Providers generally agree that patients are initially hesitant to see a provider for worsening symptoms 
of venous insufficiency and commonly only present after severe pain and ulceration has developed
 Treatment barriers for patients according to providers include: access to therapies, cost of therapies, 
and self-motivation for adherence to therapies
 Treatment barriers for providers treating these patients include: patient compliance, patient follow-up, 
lack of appropriate educational material, and access to insurance coverage for preventative treatment 
modalities
Overall Conclusions Drawn from Results
 Providers’ perception of their patients’ understanding of stasis dermatitis and its complications 
corresponds with surveyed patients’ comprehension.
 Despite most patients attempting preventative therapies, 50% had developed complications from CVI. 
This was consistent with provider reflections of delayed patient presentations until severe disease had 
developed. This demonstrates poorly controlled disease and room for implementing more aggressive 
preventative strategies and therapies.
 The discrepancy in the patient-reported lack of provider counseling on stasis dermatitis complications 
and prevention and provider-reported lack of patient compliance and follow-up suggests an 
opportunity to investigate how to better educate patients in the context of an office visit with a goal of 
adherence.
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Results & Responses continued 
Evaluation of Effectiveness & Limitations
Evaluation of Effectiveness
 This study served as a cursory glance at patient awareness of stasis dermatitis to assist providers 
with preventative counseling while also developing a handout to supplement this discussion.
 This study was effective in the sense of beginning the conversation surrounding this disease, yet in 
order to evaluate the true effectiveness of this study a secondary study would need to be performed 
on a larger cohort of patients over a longer duration. The results of these two studies could be 
compared to determine if the there is a similar trend in outcomes.
Limitations
 The size of the cohort sampled was limited to 7 participants which restricts our ability to draw 
significant conclusions and generalize our findings to the population
 The patients surveyed were based on a medical record diagnoses of stasis dermatitis or CVI, which 
relies on provider documentation and this is not always up to date
 Patients from only one primary care office were surveyed, introducing selection bias into our results
 Most patients were administered the Stasis Dermatitis Questionnaire over the telephone, thus 
preventing clinical confirmation of stasis dermatitis/CVI prior to questionnaire completion
7
Recommendation for Future Projects/Interventions
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• Distribute Stasis Dermatitis handout to patients with 
venous insufficiency or at risk of developing it due to 
comorbid conditions
• Evaluate patients’ management of venous insufficiency over time 
after being provided with this material
• Train medical assistants and nurses to assess all patients 
for chronic venous disease on initial office visit intake 
• Encourage providers to incorporate a lower extremity 
examine into their repertoire of preventative screening 
exams to assess for stasis dermatitis 
• Document any signs of venous insufficiency with images in chart for 
chronic evaluation
• Encourage providers to use the Venous Clinical Severity 
Score (VCSS)15,16 when evaluating all patients
• Document this value in the medical records for an objective 
evaluation of their chronic venous disease
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